GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA

The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SEGAL, JONATHAN, KEITH, TIM, DUBOIS, DANIEL, CROTEAU, PASCAL, PAQUIN, NOUZHA, BELOUCHI, ABDELMAJID, PAQUIN, BRUNO, FOURNIER, HELENE, RAELSON, JOHN VERNER, BRADLEY, WALTER EDWARD, VAN EERDEWEGH, PAUL, LITTLE, RANDALL, DAVID, BRUAT, VANESSA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SEGAL, JONATHAN
KEITH, TIM
DUBOIS, DANIEL
CROTEAU, PASCAL
PAQUIN, NOUZHA
BELOUCHI, ABDELMAJID
PAQUIN, BRUNO
FOURNIER, HELENE
RAELSON, JOHN VERNER
BRADLEY, WALTER EDWARD
VAN EERDEWEGH, PAUL
LITTLE, RANDALL, DAVID
BRUAT, VANESSA
description The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs. Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2008112177A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2008112177A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2008112177A23</originalsourceid><addsrcrecordid>eNrjZLBwd_Vz9XUMUPB3UwjxcFXwCPV19FMACQYrOAYH-zt7Ooa4uiiEe4Z4KAQ7e3hG-Qd4BLn6eTryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwMLQ0MjQ3NzRyNj4lQBAOv0KTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><source>esp@cenet</source><creator>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</creator><creatorcontrib>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</creatorcontrib><description>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs. Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080918&amp;DB=EPODOC&amp;CC=WO&amp;NR=2008112177A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080918&amp;DB=EPODOC&amp;CC=WO&amp;NR=2008112177A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEGAL, JONATHAN</creatorcontrib><creatorcontrib>KEITH, TIM</creatorcontrib><creatorcontrib>DUBOIS, DANIEL</creatorcontrib><creatorcontrib>CROTEAU, PASCAL</creatorcontrib><creatorcontrib>PAQUIN, NOUZHA</creatorcontrib><creatorcontrib>BELOUCHI, ABDELMAJID</creatorcontrib><creatorcontrib>PAQUIN, BRUNO</creatorcontrib><creatorcontrib>FOURNIER, HELENE</creatorcontrib><creatorcontrib>RAELSON, JOHN VERNER</creatorcontrib><creatorcontrib>BRADLEY, WALTER EDWARD</creatorcontrib><creatorcontrib>VAN EERDEWEGH, PAUL</creatorcontrib><creatorcontrib>LITTLE, RANDALL, DAVID</creatorcontrib><creatorcontrib>BRUAT, VANESSA</creatorcontrib><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><description>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs. Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwd_Vz9XUMUPB3UwjxcFXwCPV19FMACQYrOAYH-zt7Ooa4uiiEe4Z4KAQ7e3hG-Qd4BLn6eTryMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwMLQ0MjQ3NzRyNj4lQBAOv0KTw</recordid><startdate>20080918</startdate><enddate>20080918</enddate><creator>SEGAL, JONATHAN</creator><creator>KEITH, TIM</creator><creator>DUBOIS, DANIEL</creator><creator>CROTEAU, PASCAL</creator><creator>PAQUIN, NOUZHA</creator><creator>BELOUCHI, ABDELMAJID</creator><creator>PAQUIN, BRUNO</creator><creator>FOURNIER, HELENE</creator><creator>RAELSON, JOHN VERNER</creator><creator>BRADLEY, WALTER EDWARD</creator><creator>VAN EERDEWEGH, PAUL</creator><creator>LITTLE, RANDALL, DAVID</creator><creator>BRUAT, VANESSA</creator><scope>EVB</scope></search><sort><creationdate>20080918</creationdate><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><author>SEGAL, JONATHAN ; KEITH, TIM ; DUBOIS, DANIEL ; CROTEAU, PASCAL ; PAQUIN, NOUZHA ; BELOUCHI, ABDELMAJID ; PAQUIN, BRUNO ; FOURNIER, HELENE ; RAELSON, JOHN VERNER ; BRADLEY, WALTER EDWARD ; VAN EERDEWEGH, PAUL ; LITTLE, RANDALL, DAVID ; BRUAT, VANESSA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2008112177A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SEGAL, JONATHAN</creatorcontrib><creatorcontrib>KEITH, TIM</creatorcontrib><creatorcontrib>DUBOIS, DANIEL</creatorcontrib><creatorcontrib>CROTEAU, PASCAL</creatorcontrib><creatorcontrib>PAQUIN, NOUZHA</creatorcontrib><creatorcontrib>BELOUCHI, ABDELMAJID</creatorcontrib><creatorcontrib>PAQUIN, BRUNO</creatorcontrib><creatorcontrib>FOURNIER, HELENE</creatorcontrib><creatorcontrib>RAELSON, JOHN VERNER</creatorcontrib><creatorcontrib>BRADLEY, WALTER EDWARD</creatorcontrib><creatorcontrib>VAN EERDEWEGH, PAUL</creatorcontrib><creatorcontrib>LITTLE, RANDALL, DAVID</creatorcontrib><creatorcontrib>BRUAT, VANESSA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEGAL, JONATHAN</au><au>KEITH, TIM</au><au>DUBOIS, DANIEL</au><au>CROTEAU, PASCAL</au><au>PAQUIN, NOUZHA</au><au>BELOUCHI, ABDELMAJID</au><au>PAQUIN, BRUNO</au><au>FOURNIER, HELENE</au><au>RAELSON, JOHN VERNER</au><au>BRADLEY, WALTER EDWARD</au><au>VAN EERDEWEGH, PAUL</au><au>LITTLE, RANDALL, DAVID</au><au>BRUAT, VANESSA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA</title><date>2008-09-18</date><risdate>2008</risdate><abstract>The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs. Cette invention concerne la sélection d'un ensemble de marqueurs de polymorphisme utilisables dans les études d'association sur le génome entier reposant sur la cartographie des déséquilibres de liaison. En particulier, l'invention concerne les domaines de la pharmacogénomique, du diagnostic, du traitement thérapeutique, et l'utilisation des données concernant les haplotypes génétiques pour prédire la sensibilité d'un sujet à la schizophrénie et/ou sa réponse à un/des médicament(s) donné(s).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2008112177A2
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title GENEMAP OF THE HUMAN GENES ASSOCIATED WITH SCHIZOPHRENIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A55%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEGAL,%20JONATHAN&rft.date=2008-09-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2008112177A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true